Woodford postpones fund raising for trust
Neil Woodford has suspended a fresh round of fund raising for the Woodford Patient Capital Trust he launched last year.
- News
-
- Analysis
-
- Investment
-
-
-
Top story
-
-
-
- Video
-
Neil Woodford
-
-
Woodford: ‘Polarised and parochial’ Brexit debate ignores EU impact
Neil Woodford believes Brexit would cause crisis in the EU and tremors in the eurozone, but a weaker sterling could ultimately be beneficial to his funds.
-
Four heavy hitters weigh in on Brexit
Confused by all the pros and cons of a Brexit? Portfolio Adviser gives you an overview of some of the voices in the Brexit debate with the most gravitas.
-
Investor fears see gold return to top traded funds list
The BlackRock Gold and General Fund has returned to the list of top traded funds on the Share Centre.
-
Economic arguments around Brexit impact are ‘bogus’ – Woodford
Neil Woodford has said he believes the United Kingdom’s economy would not be adversely impacted by leaving the European Union, with temporary currency weakness the only real issue.
-
PA ANALYSIS: Which fund groups will profit in tougher times?
Woodford Investment Management, Standard Life Investments and BlackRock led the way in terms of retail sales in 2015, but altered market conditions this year threaten to shake things up considerably.
-
Woodford backs current strategy despite expectations of ‘worse’ 2016
The global economy is liable to have a worse 2016 than it had a 2015, says Woodford Investment Management CIO, Neil Woodford.
-
Woodford to run Openwork segregated mandate
Openwork has announced plan to launch a UK equity segregated mandate to be run by Neil Woodford.
-
Woodford seeking more money for trust
Neil Woodford is seeking to raise more money for the Woodford Patient Capital Trust he launched last year.
-
Woodford, Axa Biotech lead Share Centre’s 2015 top traded list
Woodford leads The Share Centre’s 2015 top traded funds list, after having hit the top spot seven times over the 12 month period.
-
Woodford reverses his Rolls Royce position
Neil Woodford has sold his stake in Rolls Royce after losing hope the company will turn around its fortunes.
-
Woodford hires FBI agent to protect biotech stake
Neil Woodford has hired ex-FBI agent Elliott Leary to investigate claims of financial misconduct at Northwest Biotherapeutics.
Other titles in the PA universe
